Catalogo dei prodotti della ricerca

D'ERASMO, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.889
EU - Europa 903
AS - Asia 413
AF - Africa 23
SA - Sud America 16
OC - Oceania 3
Totale 3.247
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.870
IT - Italia 527
SG - Singapore 211
SE - Svezia 113
DE - Germania 94
IN - India 89
CN - Cina 80
FI - Finlandia 39
GB - Regno Unito 29
BG - Bulgaria 25
ID - Indonesia 19
TG - Togo 19
CA - Canada 17
FR - Francia 16
NL - Olanda 16
AR - Argentina 15
RO - Romania 8
UA - Ucraina 8
IR - Iran 7
PL - Polonia 7
RU - Federazione Russa 7
CH - Svizzera 4
IE - Irlanda 4
AU - Australia 2
BE - Belgio 2
HK - Hong Kong 2
LT - Lituania 2
MX - Messico 2
PH - Filippine 2
TZ - Tanzania 2
ZA - Sudafrica 2
AM - Armenia 1
AT - Austria 1
BR - Brasile 1
GR - Grecia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
VN - Vietnam 1
Totale 3.247
Salva come PNG Salva come JPEG
Città #
Fairfield 269
Rome 194
Singapore 157
Chandler 136
Ashburn 130
Woodbridge 111
Houston 98
Cambridge 93
Wilmington 85
Santa Clara 84
Seattle 83
Princeton 64
New York 49
Ann Arbor 41
Beijing 36
Millbury 35
San Diego 35
Boston 28
Sofia 25
Plano 24
Lawrence 23
Dearborn 22
San Paolo di Civitate 22
Helsinki 21
Milan 21
Stockholm 20
Jakarta 19
Lomé 19
Des Moines 17
Federal 15
Andover 12
Fremont 12
Los Angeles 11
Monterotondo 10
Norwalk 10
Toronto 10
Falls Church 8
Frankfurt am Main 8
Kunming 8
Sacramento 8
Bermondsey 7
Bühl 7
Naples 7
Turin 7
Florence 6
Melville 6
Ottawa 6
Redwood City 6
Bologna 5
Chapel Hill 5
L’Aquila 5
Mannheim 5
Monza 5
Moscow 5
Phoenix 5
Vasto 5
Bari 4
Boardman 4
Chioggia 4
Dublin 4
Lappeenranta 4
Noci 4
Palermo 4
Paris 4
San Mateo 4
Bovezzo 3
Budrio 3
Cagliari 3
Capranica 3
Castrocielo 3
Chongqing 3
Edmonton 3
Falkenstein 3
Geneva 3
Guangzhou 3
London 3
Nanjing 3
Tehran 3
Terni 3
Treviso 3
Udine 3
Warsaw 3
Amsterdam 2
Aubusson 2
Bagni di Lucca 2
Bonefro 2
Bremen 2
Brussels 2
Camisano 2
Cercola 2
Cisliano 2
Dallas 2
Dar es Salaam 2
Giessenburg 2
Hong Kong 2
Lucera 2
Melbourne 2
Muizenberg 2
Munich 2
Pescorocchiano 2
Totale 2.288
Salva come PNG Salva come JPEG
Nome #
Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity 106
Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy 105
Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes 101
Honey, bee pollen and vegetable oil unsaponifiables in wound healing 94
Non-alcoholic fatty liver disease and subclinical atherosclerosis: a comparison of metabolically- versus genetically-driven excess fat hepatic storage 92
Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State 85
The relation between glycemic control and HDL-C in type 2 diabetes: a preliminary step forward? 84
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score 79
Evaluation of the performance of dutch lipid clinic network score in an Italian fh population: the lipigen study 78
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 78
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants 78
The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals 77
Genetic determinants and early carotid atherosclerosis: is there a role for the ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP-1) K121Q polymorphism? Preliminary results in non diabetic individuals 76
Clinical and biochemical features of different molecular etiologies of familial chylomicronemia 74
Identification and diagnosis of patients with familial chylomicronemia syndrome (FCS): Expert Panel recommendations and proposal of an FCS Score 69
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: a retrospective, single center, observational study 69
Nonalcoholic fatty liver disease (NAFLD), but not its susceptibility gene variants, influences the decrease of kidney function in overweight/obese children 67
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells 67
How ANGPTL3 Inhibition Will Help Our Clinical Practice? 66
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: a comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia 66
Bone damage in type 2 diabetes mellitus 62
HDL-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (NAFLD) 60
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes 59
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease 58
The interplay between angiopoietin-like proteins and adipose tissue: Another piece of the relationship between adiposopathy and cardiometabolic diseases? 57
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis 55
The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway 55
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid content 54
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: implications for clinical diagnosis 51
Uric acid levels in metabolic syndrome, type 2 diabetes and familial combined hyperlipidemia: a comparison 49
null 45
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways 42
EFFICACY AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THE PAN-EUROPEAN RETROSPECTIVE OBSERVATIONAL STUDY 39
Association of hypertriglyceridemia with all-cause mortality and atherosclerotic cardiovascular events in a low-risk italian population. the TG-REAL retrospective cohort analysis 38
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins 37
Familial combined hypolipidemia: Angiopoietin-like protein-3 deficiency 37
Does intervention on glycemic control influence HDL cholesterol levels in type 2 diabetes? A pilot study 36
Autosomal recessive hypercholesterolemia: update for 2020 35
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study 33
Atherogeniic dyslipidemia in metabolic syndrome, type 2 diabetes and familial combined hyperlipemia: lipid and lipoproteins profiling 33
ANGPTL3 Deficiency and Risk of Hepatic Steatosis 32
PNPLA3 I148M gene variant is not associated with metabolic syndrome and cardiometabolic risk in non-alcoholic fatty liver disease 32
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification 31
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 31
RR INTERVALS ENTROPY INCREASES BEFORE ONSET OF ATRIAL FIBRILLATION 30
Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia 29
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia 29
null 29
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 29
ApoCIII: A multifaceted protein in cardiometabolic disease 28
null 28
Impact of prior statin use on clinical outcomes in COVID-19 patients. data from tertiary referral hospitals during COVID-19 pandemic in italy 27
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 27
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia. 26
Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis 25
Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies 25
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells 24
Clinical implications of monogenic versus polygenic hypercholesterolemia: long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events 24
Is bempedoic acid a drug for female subjects? Preliminary analysis in an Italian cohort 24
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS) 24
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease 24
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 23
Elevated Serum Concentrations of Remnant Cholesterol Associate with Increased Carotid Intima-Media Thickness in Children and Adolescents. 21
Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment 21
Fifty shades of a shock 20
Elevated Serum Concentrations of Remnant Cholesterol Associate with Increased Carotid Intima-Media Thickness in Children and Adolescents 20
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4 19
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study 18
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects 18
null 17
null 16
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 15
null 15
ANGPTL3 Deficiency and Risk of Hepatic Steatosis 14
Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohort 14
null 14
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries 13
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia. insights from the Italian LIPIGEN registry 12
HEART RATE VARIABILITY AND HEART RATE TURBULENCE PARAMETERS TO STUDY NEUROVEGETATIVE PROFILE IN PATIENTS WITH OLD MYOCARDIAL INFARCTION 12
Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease 10
Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatment 10
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 8
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience 6
null 5
Real‐World Effectiveness of PCSK9 Inhibitors in Reducing LDL‐C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries 5
Recent Apolipoprotein CIII trials 5
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome 4
Lipid-lowering therapy in patients with coronary heart disease and prior stroke: Mission impossible? 4
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profile 3
New and Emerging Therapies for Dyslipidemia 3
null 3
Clinical implications of monogenic versus polygenic hypercholesterolemia: Long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events 3
Totale 3.495
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020347 0 0 0 0 0 54 96 64 54 40 22 17
2020/2021355 11 22 10 18 9 20 14 55 54 77 63 2
2021/2022710 27 26 39 9 85 47 28 65 64 44 171 105
2022/2023620 130 93 37 45 59 72 26 41 58 9 34 16
2023/2024596 69 59 28 35 46 111 28 13 20 55 69 63
2024/2025480 35 78 81 83 138 65 0 0 0 0 0 0
Totale 3.495